Patent ID: 11964977
Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The compound of Formula (I) according to claim 1 or 2, wherein, R1 is hydrogen, cyano, optionally substituted C1-C4-alkyl, optionally substituted C1-C4-alkoxy, optionally substituted C2-C4-alkenyl, optionally substituted C2-C4-alkynyl, optionally substituted C3-C8-cycloalkyl, optionally substituted, saturated or unsaturated 5-, 6-, or 7-membered heterocycle, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aryloxy, optionally substituted C1-C4-alkylcarbonyl, optionally substituted C1-C4-alkoxycarbonyl, aminocarbonyl, optionally substituted C1-C4-alkylaminocarbonyl, optionally substituted C1-C4-dialkylaminocarbonyl, optionally substituted SOp(optionally substituted alkyl or haloalkyl), amino, —NH-optionally substituted C1-C4-alkyl, or —NRaRb, wherein Ra and Rb are independently optionally substituted alkyl; or Ra and Rb may form, with the nitrogen to which they are attached, a 3-, 4-5-, 6-, 7-, or 8-membered-heterocyclyl group, which may be optionally substituted, and may include one or two additional heteroatoms selected from the group consisting of N, O and S;, R′ is hydrogen or C1-C4-alkyl;, R2 is hydrogen, halogen, cyano, nitro, —OH, optionally substituted C1-C4-alkyl, optionally substituted C1-C4-alkoxy, optionally substituted C3-C8-cycloalkyl, amino, NH-optionally substituted C1-C4-alkyl, —SF5, or —NRaRb, wherein Ra and Rb are independently optionally substituted C1-C4-alkyl; or Ra and Rb may form, with the nitrogen to which they are attached, a 3, 4, 5, 6, 7, or 8 membered-heterocyclyl group, which may be optionally substituted, and may include one or two additional heteroatoms selected from the group consisting of N, O and S; —SOp (optionally substituted C1-C4-alkyl or haloalkyl);, R3 is optionally substituted C1-C4-alkyl, optionally substituted phenyl, optionally substituted 5- to 10-membered heteroaryl, optionally substituted C3-C8-cycloalkyl, a 5- to 11-membered spirocyclic heterocyclyl-carbocyclyl group, a 5- to 11-membered spirocyclic heterocyclyl-heterocyclyl group, a 5- to 11-membered spirocyclic carbocyclyl-carbocyclyl group, or a 5- to 11-membered spirocyclic carbocyclyl-heterocyclyl group; and, each R4 is independently hydrogen, halogen, cyano, nitro, hydroxyl, optionally substituted C1-C4-alkyl, optionally substituted C1-C4-alkoxy, optionally substituted C3-C8-cycloalkyl, amino, NH-optionally substituted C1-C4-alkyl, —SF5, or —NRcRd, wherein Rc and Rd are independently optionally substituted C1-C4-alkyl; or Rc and Rd may form, with the nitrogen to which they are attached, a 3, 4, 5, 6, 7, or 8 membered-heterocyclyl group, which may be optionally substituted and may include one or two additional heteroatoms selected from the group consisting of N, O and S, SOp (optionally substituted C1-C4-alkyl or haloalkyl.